⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MBOT News
Microbot Medical, Inc. Common Stock
Form 8-K
sec.gov
MBOT
Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT
Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
globenewswire.com
MBOT
Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
globenewswire.com
MBOT
Form 8-K
sec.gov
MBOT